Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $26.00 price target on the stock. Phathom Pharmaceuticals Stock Up 1.9 % PHAT stock opened at $9.35 on Friday. The stock has a market capitalization […]
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a note issued to investors on Friday, Benzinga reports. They presently have a $26.00 price target on the stock. Needham & Company LLC’s price objective suggests a potential upside of 188.89% from the […]
Needham & Company LLC reissued their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report published on Monday morning, Benzinga reports. Needham & Company LLC currently has a $26.00 target price on the stock. Phathom Pharmaceuticals Price Performance Shares of NASDAQ:PHAT opened at $10.62 on Monday. Phathom Pharmaceuticals has a […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) insider Terrie Curran sold 16,851 shares of the business’s stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $9.11, for a total value of $153,512.61. Following the transaction, the insider now directly owns 410,784 shares in the company, valued […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) insider Terrie Curran sold 16,851 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $9.11, for a total transaction of $153,512.61. Following the sale, the insider now directly owns 410,784 shares of the […]